Mink Therapeutics Inc
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | -100.0% | – | – | -100.0% | – | – | |
| – | – | +41.6% | +56.2% | +68.1% | +5.3% | -15.6% | |
| – | -108.0% | – | – | – | – | – | |
| – | -51.6% | +46.9% | +65.5% | -33.0% | -59.1% | +90,768.4% | |
| – | -66.4% | +260.3% | +68.8% | -5.1% | +57,955.5% | +56.0% | |
| – | -53.2% | +72.5% | +66.4% | -26.3% | -54.1% | +17.9% | |
| – | – | – | – | – | – | – | |
| – | +56.4% | -0.4% | -89.6% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | -126.5% | – | – | – | -359,133,906,700.0% | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.